Bortezomib in the treatment of multiple myeloma

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...

Szczegółowa specyfikacja

Opis bibliograficzny

Wydane w:	Springer eBooks.
Korporacja:	SpringerLink (Online service)
Kolejni autorzy:	Ghobrial, Irene M., Richardson, Paul G., Anderson, Kenneth C.
Format:	Electronic Resource
Język:	English
Wydane:	Basel Springer Basel c2011.
Hasła przedmiotowe:	Multiple myeloma > Treatment. Multiple myeloma > Chemotherapy. Antineoplastic agents. Boronic Acids > Therapeutic use. Multiple myeloma > Drug therapy. Antineoplastic agents > Therapeutic use. Protease inhibitors > Therapeutic use. Proteasome endopeptidase complex > Antagonists & inhibitors. Pyrazines > Therapeutic use. Electronic books.
Dostęp online:	Available for University of the Philippines Diliman via SpringerLink. Click here to access